Back to Research

FIRST MALARIA THEN AIDS THEN CANCER NOW CORONA

A HELP FOR SELF-HELP

Dr. Hans-Martin Hirt

Dr. Hans-Martin Hirt and Team

Anamed International

Table of Contents

  1. Introducing "Anamedopathy"
  2. Introducing A-3
  3. A-3 and Malaria
  4. A-3 and AIDS
  5. A-3 and Cancer
  6. A-3 and Cancer: How it works
  7. A-3 and Corona
  8. Summary

1. Introducing Anamedopathy

ANAMED = ACTION FOR NATURAL MEDICINE is a combination of the advantages of modern medicine and traditional herbal medicine.

Natural Medicine Offers:

  • Scientific basis
  • Reliable preparation methods
  • Excellent packaging
  • Clear documentation
  • Exact dosages
  • Specific "use by" dates

Additional Benefits:

  • Uses locally available resources
  • Grounded in local language and culture
  • Available even in remote regions
  • Promotes self-reliance
  • Cost-effective
  • Sustainable

2. Introducing A-3 (Artemisia annua anamed)

A-3 is a special breed of Artemisia annua (not genetically modified) that has been specifically cultivated for its medicinal properties. It can be grown in both large plantations and small medicinal gardens.

3. A-3 and Malaria

Key Fact:

Every day, 3,000 people die from malaria. Artemisinin, the active compound in A-3, works by increasing immunity and releasing oxygen radicals that kill malaria parasites.

4. A-3 and AIDS

Artemisinin is patented as an antiretroviral drug. AIDS patients often suffer from Kaposi's Sarcoma, a form of cancer that can be positively affected by substances that stimulate the immune system, such as artemisinin.

5. A-3 and Cancer

Tumor cells share two critical characteristics that make them vulnerable to A-3 therapy:

  1. Iron Accumulation: Tumor cells accumulate excess iron, similar to malaria parasites.
  2. Immune System Vulnerability: Like HIV, cancer cells can be fought by a strong immune system.

Both artemisinin and A-3 tea destroy cells with high iron concentrations through oxygen radicals and strengthen the immune system.

6. How A-3 Works Against Cancer

A-3 contains at least 20 known anti-tumor substances, including:

  • Alpha-Amyrin
  • Apigenin
  • Artemisinin
  • Chrysosplenol-D
  • Caryophyllene-oxide
  • Kaempferol
  • Luteolin
  • Oleanolic-acid
  • Quercetin
  • Scopoletin

Key Mechanisms:

  1. Direct Cell Toxicity: Targets and destroys tumor cells through oxygen radicals.
  2. Angiogenesis Prevention: Restricts blood vessel growth to tumors.
  3. Immune System Stimulation: Enhances natural killer cell activity.
  4. Radiation Sensitivity: Increases tumor cell sensitivity to radiation therapy.
  5. Metastasis Prevention: Reduces tumor cell adhesion and spread.

7. A-3 and COVID-19

A-3 shows promise in COVID-19 management through multiple mechanisms:

As Prophylaxis:

  • Contains antiviral ingredients that may inactivate the virus
  • Boosts immunity through natural killer cells
  • Strengthens and protects the respiratory tract with essential oils

As Therapy:

  • May prevent viral spread to the lungs
  • Enhances immune response
  • Inactivates the virus through antiviral compounds
  • May help prevent cytokine storm

Dosage Recommendations:

Prophylaxis: 0.25g A-3 per 10kg body weight once daily (tea or powder)

Acute Treatment: 1g A-3 per 10kg body weight daily, divided into 2-3 doses

Long COVID: 0.25-1g per 10kg body weight daily, depending on severity

8. Summary

A-3 represents a powerful example of how traditional medicine, when combined with scientific understanding, can address multiple health challenges from malaria to cancer and viral infections like COVID-19. Its multi-faceted approach, low cost, and accessibility make it particularly valuable in resource-limited settings.

Important Note:

This information is for educational purposes only and is not intended as medical advice. Always consult with a healthcare professional before starting any treatment.

Acknowledgements

This presentation has been compiled from the work of several co-workers:

  • Florian Freyer – University of Tübingen
  • Dr. Sudowe – Ganzimmun Institute, Mainz
  • Nicolé Krützen – Queen Margaret University, Edinburgh
  • Prof. Dr. Max Moser – Medical University of Graz
  • Worldwide employees of anamed international e.V.